Arcturus Therapeutics Holdings Inc (ARCT) insider trading

Every open-market stock purchase and sale by Arcturus Therapeutics Holdings Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Andy Sassine (CFO), $20.5K, 14 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $7.30 on Jun 4, 2026.

Recent ARCT insider trades

DateInsiderTradeValue
Jun 5, 2026James F Barlow (Director)Bought (not open market)—
Jun 5, 2026John Markels (Director)Bought (not open market)—
Jun 5, 2026Moncef Slaoui (Director)Bought (not open market)—
Jun 5, 2026Magda Marquet (Director)Bought (not open market)—
Jun 5, 2026Peter C Farrell (Director)Bought (not open market)—
Jun 5, 2026Jing L. Marantz (Director)Bought (not open market)—
Jun 5, 2026Edward W Holmes (Director)Bought (not open market)—
May 1, 2026Dennis Mulroy (CFO)Bought (not open market)—
Dec 17, 2025Joseph Roberts (Officer)Bought (not open market)—
Dec 17, 2025Pad Chivukula (COO)Bought (not open market)—
Dec 17, 2025Joseph E Payne (CEO)Bought (not open market)—
Dec 17, 2025Lance Kurata (C-suite exec)Bought (not open market)—

Who's trading ARCT

Get free alerts when an insider at Arcturus Therapeutics Holdings Inc files a new trade →